The Apple Watch missed my hypertension - but this blood pressure wearable caught it instantly

A new wearable from Hilo is challenging the Apple Watch's approach to hypertension detection by providing continuous, instant blood pressure monitoring. While Apple's feature on the Series 9, Ultra 2, and later models scans for indicative patterns over a 30-day period before suggesting a cuff-based check, the Hilo device attached to a journalist's wrist flagged hypertension almost immediately. This highlights a key difference: Apple's system is designed for notification and requires follow-up, whereas Hilo aims for direct, ongoing measurement. The device represents a shift towards proactive, wearable health tech that doesn't rely solely on inferring conditions from heart rate data.

The Hilo monitor collects data throughout the day and night, amassing over 800 readings per month to build a comprehensive profile. For the data to be medically useful, the wearable requires regular calibration with a traditional blood pressure cuff. A significant caveat is its subscription model; full access to one's own health data through the app costs $80 annually after the first year. This development matters because hypertension contributes to over 1,000 U.S. deaths daily, and continuous monitoring could lead to earlier intervention. However, it also raises questions about data accessibility and cost versus the more passive, pattern-based detection method employed by mainstream smartwatches.